Descubre
- Descubre
  Informate sobre terapia génica y celular
- Educational Resources Directory
  Educational Resources Directory
- INTENS
  INtestinal Tissue ENgineering Solution
- LEARN
  Listening to the experience of participants in neurosurgical trials
Informate sobre terapia génica y celular
Research Pathways
- Research Pathways
  Bringing new therapies from the lab to patients
- Vías de investigación
  Trasladando las terapias desde el laboratorio a los pacientes
- ATMP Engage
  Advanced Therapy Medicinal Products Patient and Public Involvement and Engagement Working Group
- CARTALLEU
- Actors and Network database
  Actors and Networks database
Bringing new therapies from the lab to patients
Quiénes Somos
Nuestro equipo y socios
Contacto

Enfermedad

Atrofia muscular espinal
Cáncer
Derrame cerebral
Diabetes
Distrofia muscular
Enfermedad de Huntington
Enfermedad de las neuronas motoras
Enfermedad de Parkinson
Enfermedad Intestinal Inflamatoria
Enfermedades Autoimmunes
Enfermedades cardiovasculares
Enfermedades de la sangre
Enfermedades hepáticas
Enfermedades músculo-esqueléticas
Enfermedades neurológicas
Enfermedades oculares
Enfermedades pulmonar
Enfermedades raras
Enfermedades renales
Epidermólisis bullosa
Esclerosis múltiple
La enfermedad de Alzheimer
Lesiones de la médula espinal
Parálisis cerebral
Piel
Sangre de cordón
Reproducción y fertilidad

Tema

Aplicaciones actuales y posibles
Células iPS
Células madre de la piel
Células madre de la sangre
Células madre embrionarias
Conceptos fundamentales sobre células y genes
Edición genética
Ensayos clínicos
Ética y sociedad
Explorar las células madre
Hojas informativas
Implicación del paciente
Industria
Ingeniería tisular
Investigación
Legislación y regulación
Métodos y herramientas
Modelización de enfermedades
MSCs
Noticias sobre células madre
Organoides
Reprogramación
Sangre de cordón
Terapia celular
Terapia de células CAR-T
Terapia génica
Tratamientos no probados

Elegir idioma

English
Français
Deutsch
Italiano
Polski
Español
Português

ATMP Engage PPI Directory

The PPI Directory contains patient and public involvement (PPI) resources for developers of cell and gene therapies, including toolkits, guidelines, advice, templates and case studies.

Ruta de navegación

ATMP Engage
PPI Directory

PPI Directory

Title

PPI Themes

PPI Themes
- PPI Basics and Benefits
- Standards for PPI
- Roles and Responsibilities
- PPI Pools/Lists of Organisations
- Knowledge Building
- Strategies/Statements/Policies on PPI
- Budgeting/Compensation
- Project Planning
- How/Who to Recruit
- Using Technology
- Training
- Maintaining/Supporting PPI
- Communication/Plain Language/Glossaries
- Case Studies
- Evaluating/Recording PPI Impact
- Feedback to/from PPI

Research Field

Research Field
- General
- Biomedical Lab
- Pharmaceutical
- ATMP/Gene Therapy Development
- Other

Organisation Type

Organisation Type
- Funder
- Academia
- Healthcare
- Regulatory Body
- HTA
- Industry
- Third Sector/Charity
- Other Organisation

Development Stage

Development Stage
- Identifying/Prioritising Patient Need
- Research and Clinical Development
- Regulatory Approval
- Health Technology Assessment
- Service Delivery

Audience

Audience
- Researchers/Developers
- Public/Patients
- Charity Sector
- Industry
- Other groups

Country

Country
- UK
- Europe
- North America
- Other countries

Content Type

Content Type
- Resource
- Journal
- Repository
- Article

toolkit
partnership
NHS

Showing 5 of 171 results.

Page 16 of 35

2021

ATTC Advanced Therapies Events

The Advanced Therapy Treatment Centre (ATTC) webinar series on cell and gene therapies

Visit this Resource

Research Field

ATMP/Gene Therapy Development

Organisation Type

Other Organisation

Development Stage

Service Delivery

Audience

Public/Patients

Country

Content Type

Resource

2021

MHRA Patient Involvement Strategy 2021-25

Report outlining how the Medicines and Healthcare products Regulatory Agency (MHRA) will engage patients in their work

Visit this Resource

Research Field

Other

Organisation Type

Regulatory Body

Development Stage

Regulatory Approval

Audience

Public/Patients

Country

Content Type

Resource

Opportunities for patients and the public to be involved in the work of the MHRA

Information on how patients can be involved in work by the Medicines and Healthcare products Regulatory Agency (MHRA)

Visit this Resource

Research Field

Other

Organisation Type

Regulatory Body

Development Stage

Regulatory Approval

Audience

Public/Patients

Country

Content Type

Resource

2021

MHRA Proposed Patient and Public Involvement Strategy 2020-25

Details from a public consultation on the proposed strategy for involving patients in the Medicines and Healthcare products Regulatory Agency (MHRA)

Visit this Resource

Research Field

Other

Organisation Type

Regulatory Body

Development Stage

Regulatory Approval

Audience

Public/Patients

Country

Content Type

Resource

2021

Our responsibility to patients

Importance of working with Patients and Patient Advisory Groups by Janssen

Visit this Resource

Research Field

Pharmaceutical

Organisation Type

Industry

Development Stage

Identifying/Prioritising Patient Need
Research and Clinical Development

Audience

Public/Patients
Charity Sector

Country

Content Type

Resource

Pagination

First page
Previous page
…
Página 14
Página 15
Página 16
Página 17
Página 18
…
Next page
Last page

Who are we?

The Advanced Therapy Medicinal Products Patient and Public Involvement and Engagement Working Group (ATMP Engage) brings together UK-based stakeholders with an interest in ATMPs to discuss and collaborate on PPIE activity.

Learn more about ATMP Engage

Volver arriba

Footer menu

Términos y condiciones
Privacidad
Accesibilidad
Contáctenos

EuroGCT en Facebook EuroGCT on LinkedIn EuroGCT on BlueSky